News
Academy
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Latest Executive Roundtables
  • Asembia 2025
  • Sales Effectiveness
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe
Advertisement

Feature

Article

April 24, 2024

Identifying Healthcare Trends from Conversation Data

Author(s):

Amy Brown

Healthcare customers and patients are facing more avenues to receive misinformation about drugs than ever before.

Amy Brown

Amy Brown
founder and CEO
Authenticx

The recent explosion of weight loss drugs1 like Ozempic, fueled by online hype, has brought both opportunities and challenges to the healthcare customer experience. While demand surges, so does the potential for misinformed consumers.

Education is crucial to ensure a positive customer experience amidst this frenzy. We need to find ways to “set the record straight” about misinformation circulating online. Customers who encounter inaccurate information may attempt to access services they’re not eligible for or seek medicines for inappropriate uses. This can lead to confusion, frustration and repeated interactions with customer service as they try to navigate the situation–a cycle that perfectly embodies the repetitive nature of The Eddy Effect™2, or instances of consumers getting ‘stuck’ in the customer journey, which results in a negative customer experience.

This article will discuss how analyzing the changing voices of customer populations not only provides valuable insights but also identifies possible emerging trends.

Misinformation poses significant CX challenges

Having visibility into sudden shifts in conversation about the use of a specific medication or service to achieve a certain health outcome could indicate the ongoing spread of misinformation online. When healthcare organizations recognize these trends, they can address the issue via targeted communication and education efforts.

This proactive approach can directly reduce call center volumes and customer frustration. Identifying the platforms where people share information–from social media to online forums–is key to crafting targeted messages clarifying facts, emphasizing safe and appropriate medication use, and guiding customers toward reliable sources of information.

How might an organization identify the need for such messaging? By listening to its conversation data.

Imagine a customer exclaiming, “TikTok said I could get a prescription for [this amount]!” or another questioning, “My spouse got a prescription for [a specified drug], why can’t I?” These scenarios–along with confusion about eligibility or potential side effects–can lead to a surge in contact center calls and strain internal resources.

Collecting, aggregating and monitoring data from conversations over time allows healthcare organizations to spot trends early–before they go viral. AI can listen at scale, analyzing conversations to pinpoint root causes of customer concerns, like issues with medication access or confusion about side effects. Conversational intelligence also surfaces when customers become stuck in frustrating, repetitive cycles because of obstacles or disruptions in their healthcare journeys, including prior authorization or medication eligibility issues.

These insights allow leaders to anticipate trends, prepare appropriate responses, and proactively address potential issues. In essence, harnessing the power of conversational data empowers healthcare organizations to navigate the dynamic healthcare landscape, educate customers and deliver a positive customer experience.

Harnessing conversational data to educate and prepare

Analyzing interactions from call centers, online platforms and other touch points to understand customer concerns and hone in on trending topics enables organizations to craft messaging that counteracts misinformation more effectively. Think of it like tracking weather patterns to anticipate a storm.

Real-time monitoring keeps you on top of emerging and ongoing situations. During high-demand volume surges, organizations can provide public health guidance through various channels, addressing concerns and managing expectations–just like local news stations issuing real-time weather updates.

Turning insights into actionable strategies

Beyond crisis management, conversational data opens doors to improvement. Healthcare leaders can use feedback to update processes, agent scripts and training materials. Chatbots and virtual assistants on websites and mobile apps can answer common health questions, providing evidence-based information. Organizations can deploy and invite their customers to use interactive health information platforms to explore health topics, debunk myths and get personalized guidance based on their needs.

With the explosion of online health information, viral trends and misleading content pose significant challenges to customer experience, making the ability to detect and respond to emerging trends invaluable. By embracing a data-driven approach and leveraging conversational AI insights, healthcare organizations can confidently navigate fads to provide education and exceptional care delivery while maintaining operational efficiency. Proactive healthcare communication fosters a well-informed patient population and strengthens the foundation of public health.

Amy Brown is the founder and CEO of Authenticx.

Sources

  1. The Messy Rise of Weightloss Drugs. Business Insider. December 29, 2023. https://www.businessinsider.com/weight-loss-glp-1-drugs-ozempic-wegovy-mounjaro-effects-future-2023-12?utm_medium=newsletter&utm_source=Sailthru&utm_campaign=Insider_Today
  2. The Eddy Effect. Authenticx. https://authenticx.com/eddy-effect/

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Related Content
Advertisement
Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027
August 2nd 2025

Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027

Don Tracy, Associate Editor
Facing patent expiration for its blockbuster Keytruda, Merck aims to streamline operations with significant job cuts and continued R&D investments.
Cell and Gene Therapy Check-in 2024
August 2nd 2025

Cell and Gene Therapy Check-in 2024

Miranda Schmalfuhs
Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.
Earned Media and PBMs: Proactive Pathways for Image Boost
August 2nd 2025

Earned Media and PBMs: Proactive Pathways for Image Boost

Michael Christel
Insights on ways pharmacy benefit managers can tap earned media to enhance their reputation—and demonstrate value through transparency, storytelling, and leveraging data to improve patient care.
Industry Outlook 2022
August 2nd 2025

Industry Outlook 2022

Elaine Quilici Miranda Schmalfuhs
Our milestone 100th episode includes Lisa Henderson, group editorial director; Julian Upton, European and online editor; Fran Pollaro, senior editor; and Andy Studna, associate editor, discussing industry trends in areas such as Chinese biotech, corporate branding, psychedelic medicines, and market access barriers.
Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down Amid Strategic Leadership Transition
August 2nd 2025

Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down Amid Strategic Leadership Transition

Don Tracy, Associate Editor
Jørgensen will step down after eight years as CEO, with a successor search underway while the company reaffirms confidence in its strategic plans amid recent market challenges.
Earned Media and ASCO: Provide Context Beyond the Data
August 2nd 2025

Earned Media and ASCO: Provide Context Beyond the Data

Michael Christel
The latest Q&A installment in Pharm Exec's earned media series details key strategies for leveraging breaking news at industry trade shows, including the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting.
Related Content
Advertisement
Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027
August 2nd 2025

Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027

Don Tracy, Associate Editor
Facing patent expiration for its blockbuster Keytruda, Merck aims to streamline operations with significant job cuts and continued R&D investments.
Cell and Gene Therapy Check-in 2024
August 2nd 2025

Cell and Gene Therapy Check-in 2024

Miranda Schmalfuhs
Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.
Earned Media and PBMs: Proactive Pathways for Image Boost
August 2nd 2025

Earned Media and PBMs: Proactive Pathways for Image Boost

Michael Christel
Insights on ways pharmacy benefit managers can tap earned media to enhance their reputation—and demonstrate value through transparency, storytelling, and leveraging data to improve patient care.
Industry Outlook 2022
August 2nd 2025

Industry Outlook 2022

Elaine Quilici Miranda Schmalfuhs
Our milestone 100th episode includes Lisa Henderson, group editorial director; Julian Upton, European and online editor; Fran Pollaro, senior editor; and Andy Studna, associate editor, discussing industry trends in areas such as Chinese biotech, corporate branding, psychedelic medicines, and market access barriers.
Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down Amid Strategic Leadership Transition
August 2nd 2025

Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down Amid Strategic Leadership Transition

Don Tracy, Associate Editor
Jørgensen will step down after eight years as CEO, with a successor search underway while the company reaffirms confidence in its strategic plans amid recent market challenges.
Earned Media and ASCO: Provide Context Beyond the Data
August 2nd 2025

Earned Media and ASCO: Provide Context Beyond the Data

Michael Christel
The latest Q&A installment in Pharm Exec's earned media series details key strategies for leveraging breaking news at industry trade shows, including the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting.
About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.